July 8 (Reuters) - Recce Pharmaceuticals Ltd RCE.AX :
* ENTERED INTO ANTIVIRAL SARS-COV-2 SCREENING PROGRAM AGREEMENT WITH COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
* ENTERED INTO ANTIVIRAL SARS-COV-2 SCREENING PROGRAM AGREEMENT UNIVERSITY OF MELBOURNE ALSO